# The Effects of Dietary Supplements on Glycemic Control, Body Composition and Hepatic Fat Content in People With Prediabetes

> **NCT06437938** · NA · RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 50 (estimated)

## Conditions studied

- PreDiabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary supplement A: Wasabi leaf powder (product of BIOGENA GmbH & Co KG)
- **DIETARY_SUPPLEMENT:** Dietary supplement B: Berberin Phytoactive Gold (product of BIOGENA GmbH & Co KG)
- **DIETARY_SUPPLEMENT:** Dietary supplement C: DiaPhyt® Formula 3.0 (product of BIOGENA GmbH & Co KG)
- **OTHER:** Placebo group 1: Placebo capsules corresponding to DiaPhyt® Formula 3.0/Berberin Phytoactive Gold
- **OTHER:** Placebo group 2: Placebo powder corresponding to Wasabi leaf powder

## Key facts

- **NCT ID:** NCT06437938
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-25
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06437938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06437938, "The Effects of Dietary Supplements on Glycemic Control, Body Composition and Hepatic Fat Content in People With Prediabetes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06437938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
